Picture of Kits Eyecare logo

KITS Kits Eyecare News Story

0.000.00%
ca flag iconLast trade - 00:00
Consumer CyclicalsAdventurousSmall CapFalling Star

Canada's Kits Eyecare prelim Q1 sales rise on glasses unit strength

Overview

Canada eyecare provider's preliminary Q1 revenue grew 23% yr/yr but missed analyst expectations

Adjusted EBITDA for preliminary Q1 exceeded 6% of revenue

Preliminary glasses revenue expanded 61% yr/yr to C$10.8 mln

Outlook

Company did not provide specific guidance for upcoming quarters or the full year in its press release

Result Drivers

GLASSES SEGMENT - Glasses revenue grew 61% yr/yr to C$10.8 mln, contributing to overall revenue growth

MARGIN IMPROVEMENT - Adjusted EBITDA exceeded 6% of revenue, up quarter-over-quarter

Company press release: ID:nCNWT29qda

Key Details

MetricBeat/MissActualConsensus Estimate
Q1 RevenueMissC$57.40 mlnC$59.12 mln (5 Analysts)
Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", no "hold" and no "sell" or "strong sell" The average consensus recommendation for the miscellaneous specialty retailers peer group is "buy" Wall Street's median 12-month price target for Kits Eyecare Ltd is C$25.00, about 60.8% above its April 6 closing price of C$15.55 The stock recently traded at 51 times the next 12-month earnings vs. a P/E of 64 three months ago For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Kits Eyecare

See all news